The entity of immunoglobulin A-related anaphylactic transfusion reactions is not evidence based

Transfusion

Volumn 55, Issue 1, 2015, Pages 199-204

  Sandler, S Gerald ^a   Eder, Anne F ^b   Goldman, Mindy ^c   Winters, Jeffrey L ^d  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b National Headquarters Biomedical Services American Red Cross   (United States)

^c CANADIAN BLOOD SERVICES   (Canada)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; ANTI-IGA; ANTIIDIOTYPIC ANTIBODY;

ALLERGIC REACTION; ANAPHYLAXIS; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; COMMON VARIABLE IMMUNODEFICIENCY; DIFFERENTIAL DIAGNOSIS; ERYTHROCYTE; HEMAGGLUTINATION; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; INCIDENCE; MULTIPLE MYELOMA; NOTE; OXYGEN SATURATION; SENSITIZATION; TRANSFUSION RELATED ACUTE LUNG INJURY; URTICARIA; ADVERSE EFFECTS; AUSTRALIA; BLOOD; BLOOD SAFETY; CANADA; EUROPE; EVIDENCE BASED MEDICINE; IGA DEFICIENCY; IMMUNOLOGY; PATHOPHYSIOLOGY; STANDARDS; TRANSFUSION REACTION; UNITED STATES; UNNECESSARY PROCEDURE;

ANAPHYLAXIS; ANTIBODIES, ANTI-IDIOTYPIC; AUSTRALIA; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; CANADA; CAUSALITY; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; IGA DEFICIENCY; IMMUNOGLOBULIN A; INCIDENCE; TRANSFUSION REACTION; UNITED STATES; UNNECESSARY PROCEDURES;

EID: 84920871095     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12796     Document Type: Note

References (32)

1. Vyas GN, Perkins HA, Fudenberg HH,. Anaphylactoid transfusion reactions associated with anti-IgA. Lancet 1968; 2: 312-315.
2. Eckrich R, Mallory D, Sandler SG,. Laboratory tests to exclude IgA deficiency in the investigation of suspected anti-IgA transfusion reactions. Transfusion 1993; 33: 488-492.
3. Sandler SG, Eckrich R, Malamut D, et al. Hemagglutination assays for the diagnosis and prevention of anaphylactic transfusion reactions. Blood 1994; 84: 2031-2035.
4. Sandler SG, Mallory D, Malamut D, et al. IgA anaphylactic transfusion reactions. Transfus Med Rev 1995; 9: 1-8.
5. Yu H, Sandler SG,. IgA anaphylactic transfusion reactions. Transfus Med Hemother 2003; 30: 214-220.
6. Sandler SG, Zantek ND,. IgA anaphylactic transfusion reactions: clinical management. Immunohematology 2004; 20: 234-238.
7. Sandler SG,. How I mange IgA anaphylactic transfusion reactions. Transfusion 2006; 46: 10-13.
8. Sandler SG, Vassallo RR,. Anaphylactic transfusion reactions. Transfusion 2011; 51: 2265-2266.
9. Mallory D, Malamut D, Sandler SG,. A decade of rare donor services in the United States/report of the American Red Cross rare donor registry (1981-1990). Vox Sang 1992; 63: 186-191.
10. Flickinger C, Petrone T, Church A,. Review. American rare donor program. Immunohematology 2004; 20: 239-248.
11. Mourant AE,. The establishment of the International Panel of Rare Blood Donors. Vox Sang 1965; 10: 129-132.
12. Anstee D, Levene C, Mallory D, et al. Rare blood. An ISBT working party report on rare blood donors. Vox Sang 1999; 77: 58-62.
13. Novaretti M, Woodfield G,. An international survey on rare blood activities. Transfusion Today, Sept 2001, pp. 6-7.
14. Palmer DS, O'Toole J, Montreuil T, et al. Screening of Canadian Blood Services donors for severe immunoglobulin A deficiency. Transfusion 2010; 50: 1524-1531.
15. Pandey S, Vyas GN,. Adverse effects of plasma transfusion. Transfusion 2012; 52: 65S-79S.
16. Savage WJ, Tobian AAR, Savage H, et al. Scratching the surface of allergic transfusion reactions. Transfusion 2013; 54: 1362-1371.
17. Eder AF, Chambers LA,. Noninfectious complications of blood transfusion. Arch Pathol Lab Med 2007; 131: 708-718.
18. Lieberman RA, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126: 477-480.
19. Vassallo RR,. Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence, and supply of IgA deficient products. Immunohematology 2004; 20: 226-233.
20. McGuckin S, Westwood J, Webster H, et al. Characterization of the complications associated with plasma exchange for thrombotic thrombocytopenic purpura and related thrombotic microangiopathic anemias: a single institution experience. Vox Sang 2014; 106: 161-166.
21. Gilstad CW, Kessler C, Sandler SG,. Transfusing patients with anti-immunoglobulin A subclass antibodies. Vox Sang 2002; 83: 363.
22. Steering Group. UK hemovigilance reports, 2011 and 2012. Serious Hazards of Transfusion (SHOT). 2013. [cited 31 Jul 2013]. Available from: http://www.shotuk.org/shot-reports/
23. Agence Nationale de sécurité du médicament et des produits de santé (ANSM). French hemovigilance report, 2012. [cited 31 Jul 2013]. Available from: http://ansm.sante.fr/var/ansm-site/storage/original/application/94eaed87fcb1d3c9d2187f4945256875.pdf
24. Brand A, te Boekhorst PW, Koopman-van Gemert AW, et al.; for the TRIP Foundation. Dutch hemovigilance report, Transfusion Reactions in Patients (TRIP), 2012. [cited 31 Jul 2013]. Available from: http://www.tripnet.nl/pages/en/documents/TRIP2011HemovigilanceExtendedversion.pdf
25. Cong S, Hyland P, Mohajeri M, Akers C, McArdle for the National Blood Authority and the Haemovigilance Advisory Committee. Australian hemovigilance report, National Blood Authority 2010. [cited 31 Jul 2013]. Available from: http://www.blood.gov.au/haemovigilance-reporting
26. Comité d'hémovigilance du Québec. Québec hemovigilance report, 2010. [cited 31 Jul 2013]. Available from: http://publications.msss.gouv.qc.ca/acrobat/f/documentation/2011/11-933-01F.pdf
27. Center for Biologics Evaluation and Research. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2012. [cited 4 May 2014]. Available from: http://www.fda.gov/biologicsbloodvaccines/safetyavailability/reportaproblem/transfusiondonationfatalities/ucm346639.htm
28. Whitaker B, Henry RA,. 2011 National Blood Collection and Utilization Survey Report. Department of Health and Human Services. 2013.
29. Arnold DM, Blajchman MA, DiTomasso J, et al. Passive transfer of peanut hypersensitivity by fresh frozen plasma. Arch Intern Med 2007; 167: 853-854.
30. Winters JL, Moore SB, Sandness C, et al. Transfusions of apheresis PLTS from IgA-deficient donors with anti-IgA is not associated with an increase in transfusion reactions. Transfusion 2004; 44: 382-385.
31. Vyas GN, Perkins HA, Yang YM, et al. Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA. J Lab Clin Med 1975; 85: 838-842.
32. Robitaille N, Delage G, Long A, et al. Allergic transfusion reactions from blood components donated by IgA-deficient donors with and without anti-IgA: a comparative retrospective study. Vox Sang 2010; 99: 136-141.